Rekombinanter LYPD3 Antikörper
Kurzübersicht für Rekombinanter LYPD3 Antikörper (ABIN7091336)
Target
Alle LYPD3 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- LYPD3 Recombinant Antibody
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LYPD3
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:500-2000), IHC-P(1:200-500), IHC-F(1:200-500), IF(1:50-100), ICC/IF(1:50-100)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LYPD3 (LY6/PLAUR Domain Containing 3 (LYPD3))
-
Andere Bezeichnung
- LYPD3
-
Hintergrund
-
Synonyms: C4.4A, FLJ10525, GPI-anchored metastasis-associated protein C4.4A homolog, GPI-anchored metastasis-associated protein homolog, Ly6/PLAUR domain-containing protein 3, LYPD3_HUMAN, Matrigel-induced gene C4 protein, MIG-C4, SHINC3.
Background: Predicted to enable laminin binding activity. Predicted to act upstream of or within cell-matrix adhesion. Located in extracellular space. [provided by Alliance of Genome Resources, Nov 2021]
-
Gen-ID
- 27076
-
UniProt
- O95274
Target
-